Evidence map›Paper›PMID 25483063›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Spermidine protects against α-synuclein neurotoxicity.

Sabrina Büttner, Filomena Broeskamp, Cornelia Sommer, Maria Markaki, Lukas Habernig, Ali Alavian-Ghavanini, Didac Carmona-Gutierrez, Tobias Eisenberg, Eva Michael, Guido Kroemer and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Toxics · 2023
    Review
  19. ComparativeFrontiers in neuroscience · 2023
    Article
  20. Frontiers in neuroscience · 2023
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 5 countries.

Sabrina Büttnera Institute of Molecular Biosciences ; University of Graz ; Graz , Austria.
Filomena Broeskamp
Cornelia Sommer
Maria Markaki
Lukas Habernig
Ali Alavian-Ghavanini
Didac Carmona-Gutierrez
Tobias Eisenberg
Eva Michael
Guido Kroemer
Nektarios Tavernarakis
Stephan J Sigrist
Frank Madeo
Freie Universität Berlin · DEUniversity of Graz · ATFoundation for Research and Technology Hellas · GRHôpital Européen Georges-Pompidou · FR

Funding

Austrian Science Fund FWF I 1000Austrian Science Fund FWF P 24381Austrian Science Fund FWF V 235Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

As our society ages, neurodegenerative disorders like Parkinson`s disease (PD) are increasing in pandemic proportions. While mechanistic understanding of PD is advancing, a treatment with well tolerable drugs is still elusive. Here, we show that administration of the naturally occurring polyamine spermidine, which declines continuously during aging in various species, alleviates a series of PD-related degenerative processes in the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans, two established model systems for PD pathology. In the fruit fly, simple feeding with spermidine inhibited loss of climbing activity and early organismal death upon heterologous expression of human α-synuclein, which is thought to be the principal toxic trigger of PD. In this line, administration of spermidine rescued α-synuclein-induced loss of dopaminergic neurons, a hallmark of PD, in nematodes. Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy, suggesting that this cytoprotective process may be responsible for the beneficial effects of spermidine administration.

Indexed as

alpha-SynucleinAnimalsAutophagyCaenorhabditis elegansDisease Models, AnimalDopaminergic NeuronsDrosophila melanogasterHumansManganeseMotor ActivityParkinson DiseaseProtective AgentsSpermidinealpha-SynucleinManganeseProtective AgentsSpermidineagingautophagydopaminergic neuron lossmotor dysfunctionneurodegenerationParkinson's diseaseSpermidineα-synuclein

Identifiers

PMID25483063
PMCPMC4614020
OpenAlexW1976775619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.